Associate Professor, Department of Epigenetics and Molecular Carcinogenesis
Division of Basic Science Research
The University of Texas MD Anderson Cancer Center
Smithville, Texas, USA
Dr. Taiping Chen is an associate professor in the Department of Epigenetics and Molecular Carcinogenesis at The University of Texas MD Anderson Cancer Center. He obtained his Ph.D. in 2000 from McGill University (Montreal, Quebec, Canada), where he characterized the biochemical properties and biological functions of the GSG/STAR family of RNA-binding proteins. He then did his postdoctoral training at Massachusetts General Hospital, Harvard Medical School. Supported by fellowships from the Human Frontier Science Program and Canadian Institutes of Health Research, he conducted research on how DNA methylation is regulated during mouse development. In early 2004, Dr. Chen was recruited to Novartis Institutes for Biomedical Research (Cambridge, Massachusetts, USA) as a research investigator and laboratory head. The research in his group focused on the crosstalk between DNA methylation and histone modifications in a variety of biological processes, including embryogenesis, genomic imprinting, and stem cell functions. In September 2011, Dr. Chen returned to academia and joined the faculty of MD Anderson Cancer Center. His group is continuing their work on the roles of epigenetic modifiers in mammalian development and diseases. In 2011, he received a Rising Star Award from Cancer Prevention and Research Institute of Texas (CPRIT).